Inventor · disambiguated record
Steven M. Ansell
Also filed as: ANSELL STEVEN · ANSELL STEVEN M · ANSELL STEVEN MICHIAL
36 granted patents·13 pending applications·4,057 citations·filing 1995–2024
99Inventor score
Files withACUITAS THERAPEUTICS INC22INEX PHARMACEUTICALS CORP7ARBUTUS BIOPHARMA CORP6UNIV BRITISH COLUMBIA3CHEN JIANXIN2
Top patents by PatentIndex Score
49 records- 0199US11648324B2Lipids and lipid nanoparticle formulations for delivery of nucleic acidsACUITAS THERAPEUTICS INC·Filed 2021·Granted May 16, 2023·5 cites·6 claims
- 0299US11634379B2Lipids and lipid nanoparticle formulations for delivery of nucleic acidsACUITAS THERAPEUTICS INC·Filed 2020·Granted Apr 25, 2023·7 cites·25 claims
- 0399US11040112B2Lipids and lipid nanoparticle formulations for delivery of nucleic acidsACUITAS THERAPEUTICS INC·Filed 2018·Granted Jun 22, 2021·26 cites·34 claims
- 0499US10723692B2Lipids and lipid nanoparticle formulations for delivery of nucleic acidsACUITAS THERAPEUTICS INC·Filed 2018·Granted Jul 28, 2020·59 cites·34 claims
- 0599US10221127B2Lipids and lipid nanoparticle formulations for delivery of nucleic acidsACUITAS THERAPEUTICS INC·Filed 2016·Granted Mar 5, 2019·136 cites·51 claims
- 0699US10166298B2Lipids and lipid nanoparticle formulations for delivery of nucleic acidsACUITAS THERAPEUTICS INC·Filed 2016·Granted Jan 1, 2019·125 cites·39 claims
- 0799US9738593B2Lipids and lipid nanoparticle formulations for delivery of nucleic acidsACUITAS THERAPEUTICS INC·Filed 2015·Granted Aug 22, 2017·87 cites·47 claims
- 0899US9737619B2Lipids and lipid nanoparticle formulations for delivery of nucleic acidsACUITAS THERAPEUTICS INC·Filed 2017·Granted Aug 22, 2017·78 cites·27 claims
- 0999US6320017B1Polyamide oligomersINEX PHARMACEUTICALS CORP·Filed 1998·Granted Nov 20, 2001·444 cites·24 claims
- 1098US11357856B2Lipids for delivery of active agentsACUITAS THERAPEUTICS INC·Filed 2018·Granted Jun 14, 2022·20 cites·20 claims
- 1198US11168051B2Lipids and lipid nanoparticle formulations for delivery of nucleic acidsACUITAS THERAPEUTICS INC·Filed 2019·Granted Nov 9, 2021·20 cites·24 claims
- 1298US9186325B2Lipids and compositions for the delivery of therapeuticsMANOHARAN MUTHIAH·Filed 2009·Granted Nov 17, 2015·100 cites·19 claims
- 1398US7811602B2Liposomal formulations comprising dihydrosphingomyelin and methods of use thereofTEKMIRA PHARMACEUTICALS CORP·Filed 2005·Granted Oct 12, 2010·95 cites·18 claims
- 1498US6858225B2Lipid-encapsulated polyanionic nucleic acidINEX PHARMACEUTICALS CORP·Filed 2001·Granted Feb 22, 2005·433 cites·21 claims
- 1598US6287591B1Charged therapeutic agents encapsulated in lipid particles containing four lipid componentsINEX PHARMACEUTICALS CORP·Filed 1998·Granted Sep 11, 2001·334 cites·72 claims
- 1697US9394234B2Lipid formulationsTEKMIRA PHARMACEUTICALS CORP·Filed 2014·Granted Jul 19, 2016·117 cites·10 claims
- 1797US8802644B2Lipid formulationCHEN JIANXIN·Filed 2012·Granted Aug 12, 2014·124 cites·35 claims
- 1897US8158601B2Lipid formulationCHEN JIANXIN·Filed 2010·Granted Apr 17, 2012·777 cites·30 claims
- 1997US8021686B2Lipid-encapsulated polyanionic nucleic acidUNIV BRITISH COLUMBIA·Filed 2008·Granted Sep 20, 2011·63 cites·15 claims
- 2097US7341738B2Lipid-encapsulated polyanionic nucleic acidUNIV BRITISH COLUMBIA·Filed 2003·Granted Mar 11, 2008·117 cites·26 claims
- 2196US6835395B1Composition containing small multilamellar oligodeoxynucleotide-containing lipid vesiclesUNIV BRITISH COLUMBIA·Filed 2000·Granted Dec 28, 2004·171 cites·9 claims
- 2296US6586559B2Polyamide oligomersINEX PHARMACEUTICALS CORP·Filed 2001·Granted Jul 1, 2003·65 cites·28 claims
- 2396US5753613ACompositions for the introduction of polyanionic materials into cellsINEX PHARMACEUTICALS CORP·Filed 1995·Granted May 19, 1998·245 cites·4 claims
- 2494US11712481B2Lipid nanoparticle formulationsACUITAS THERAPEUTICS INC·Filed 2017·Granted Aug 1, 2023·11 cites·35 claims
- 2594US8486924B2Taxane delivery systemANSELL STEVEN M·Filed 2008·Granted Jul 16, 2013·49 cites·16 claims
- 2693US12453776B2Lipids and compositions for the delivery of therapeuticsARBUTUS BIOPHARMA CORP·Filed 2024·Granted Oct 28, 2025·0 cites·46 claims
- 2793US11820728B2Carbonyl lipids and lipid nanoparticle formulations for delivery of nucleic acidsACUITAS THERAPEUTICS INC·Filed 2018·Granted Nov 21, 2023·4 cites·26 claims
- 2893US11077197B2Lipids and compositions for the delivery of therapeuticsARBUTUS BIOPHARMA CORP·Filed 2017·Granted Aug 3, 2021·3 cites·17 claims
- 2993US9463247B2Branched alkyl and cycloalkyl terminated biodegradable lipids for the delivery of active agentsALNYLAM PHARMACEUTICALS INC·Filed 2012·Granted Oct 11, 2016·24 cites·29 claims
- 3093US5785992ACompositions for the introduction of polyanionic materials into cellsINEX PHARMACEUTICALS CORP·Filed 1995·Granted Jul 28, 1998·175 cites·6 claims
- 3192US2025034081A1Novel lipids and lipid nanoparticle formulations for delivery of nucleic acidsACUITAS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3291US12129223B2Lipids for use in lipid nanoparticle formulationsACUITAS THERAPEUTICS INC·Filed 2022·Granted Oct 29, 2024·4 cites·26 claims
- 3391US9707292B2Lipids and compositions for the delivery of therapeuticsARBUTUS BIOPHARMA CORP·Filed 2015·Granted Jul 18, 2017·5 cites·12 claims
- 3491US6027726AGlycosylated protein-liposome conjugates and methods for their preparationINEX PHAMACEUTICALS CORP·Filed 1995·Granted Feb 22, 2000·134 cites·4 claims
- 3589US12042541B2Lipids and compositions for the delivery of therapeuticsARBUTUS BIOPHARMA CORP·Filed 2023·Granted Jul 23, 2024·0 cites·23 claims
- 3685US2024075163A1Novel lipids and lipid nanoparticle formulations for delivery of nucleic acidsACUITAS THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3778US11712476B2Lipids and compositions for the delivery of therapeuticsARBUTUS BIOPHARMA CORP·Filed 2021·Granted Aug 1, 2023·0 cites·16 claims
- 3872US2025188020A1Lipids for use in lipid nanoparticle formulationsACUITAS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3972US2025161227A1Pegylated lipidsACUITAS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 4071US2025188016A1Cationic lipid compounds for use in lipid nanoparticlesACUITAS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 4171US2022204439A1Lipids and lipid nanoparticle formulations for delivery of nucleic acidsACUITAS THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 4269US2024122854A1Novel carbonyl lipids and lipid nanoparticle formulations for delivery of nucleic acidsACUITAS THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 4367US12491261B2Lipid nanoparticle formulationsACUITAS THERAPEUTICS INC·Filed 2023·Granted Dec 9, 2025·0 cites·73 claims
- 4463US2017143631A1Lipid formulationARBUTUS BIOPHARMA CORP·Filed 2016·Application pending·0 cites
- 4560US2005008689A1High efficiency encapsulation of charged therapeutic agents in lipid vesiclesINEX PHARMACEUTICALS CORP·Filed 2004·Application pending·0 cites
- 4658US2012114831A1High efficiency encapsulation of charged therapeutic agents in lipid vesiclesSEMPLE SEAN C·Filed 2011·Application pending·0 cites
- 4756US2025375464A1Formulations for modulating myc expressionFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2023·Application pending·0 cites
- 4846US2019022247A1Lipids and lipid nanoparticle formulations for delivery of nucleic acidsACUITAS THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 4943US2018185516A1Delivery of target specific nucleasesSANGAMO THERAPEUTICS INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Steven M. Ansell files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →